Now, before you get all up in arms and say, "how can you even think about supporting a middle eastern terrorist group?!", let me explain. First of all, I'm not talking about ISIS the Islamic state now known as IS, I will be discussing and analyzing the stock of Isis Pharmaceuticals, Inc. (NASDAQ:ISIS). It is just unfortunate that they happen to have the same name.
Yesterday, there was a major trend change signal in ISIS Pharmaceuticals. This signal indicated that the trend had reversed to the upside and a long position was now warranted. Technically, the stock looks very good and capable of moving another 10% to 15% higher from current levels.
To learn more about how you can take advantage of the situation in the stock of of Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), check out today's video.
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company's flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol. It also has a pipeline of 31 drugs in development for the treatment of various diseases, including cardiovascular and metabolic diseases; severe and rare diseases, including neurological disorders; and cancer. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) was founded in 1989 and is headquartered in Carlsbad, California.
Every success with MarketClub,